Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma
- PMID: 24735374
- PMCID: PMC4029990
- DOI: 10.1186/1465-9921-15-46
Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma
Abstract
Background: Asthma is estimated to affect as many as 300 million people worldwide and its incidence and prevalence are rapidly increasing throughout the world, especially in children and within developing countries. Recently, there has been a growing interest in the use of potentially beneficial bacteria for allergic diseases. This study is aimed at exploring the therapeutic effects of long-term treatment with two different beneficial bacterial strains (Bifidobacterium breve M-16 V and Lactobacillus rhamnosus NutRes1) and a glucocorticoid (budesonide), as a reference treatment, on inflammatory response in a murine model for chronic allergic asthma.
Methods: To mimic the chronic disease in asthmatic patients, we used the murine ovalbumin-induced asthma model combined with prolonged allergen exposure. Airway function; pulmonary airway inflammation; airway remodelling, mRNA expression of pattern recognition receptors, Th-specific cytokines and transcription factors in lung tissue; mast cell degranulation; in vitro T cell activation; and expression of Foxp3 in blood Th cells were examined.
Results: Lactobacillus rhamnosus reduced lung resistance to a similar extent as budesonide treatment in chronically asthmatic mice. Pulmonary airway inflammation, mast cell degranulation, T cell activation and airway remodelling were suppressed by all treatments. Beneficial bacteria and budesonide differentially modulated the expression of toll-like receptors (TLRs), nod-like receptors (NLRs), cytokines and T cell transcription factors. Bifidobacterium breve induced regulatory T cell responses in the airways by increasing Il10 and Foxp3 transcription in lung tissue as well as systemic by augmenting the mean fluorescence intensity of Foxp3 in blood CD4+ T cells.
Conclusion: These findings show that Bifidobacterium breve M-16 V and Lactobacillus rhamnosus NutRes1 have strong anti-inflammatory properties that are comparable to budesonide and therefore may be beneficial in the treatment of chronic asthma.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4029990/bin/1465-9921-15-46-1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4029990/bin/1465-9921-15-46-2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4029990/bin/1465-9921-15-46-3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4029990/bin/1465-9921-15-46-4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4029990/bin/1465-9921-15-46-5.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4029990/bin/1465-9921-15-46-6.gif)
![Figure 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4029990/bin/1465-9921-15-46-7.gif)
![Figure 8](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4029990/bin/1465-9921-15-46-8.gif)
![Figure 9](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4029990/bin/1465-9921-15-46-9.gif)
Similar articles
-
The combination of Bifidobacterium breve with non-digestible oligosaccharides suppresses airway inflammation in a murine model for chronic asthma.Biochim Biophys Acta. 2014 Apr;1842(4):573-83. doi: 10.1016/j.bbadis.2014.01.005. Epub 2014 Jan 15. Biochim Biophys Acta. 2014. PMID: 24440361
-
Lactobacillus rhamnosus probiotic prevents airway function deterioration and promotes gut microbiome resilience in a murine asthma model.Gut Microbes. 2020 Nov 1;11(6):1729-1744. doi: 10.1080/19490976.2020.1766345. Epub 2020 Jun 10. Gut Microbes. 2020. PMID: 32522072 Free PMC article.
-
Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma.Clin Exp Allergy. 2007 Apr;37(4):498-505. doi: 10.1111/j.1365-2222.2006.02629.x. Clin Exp Allergy. 2007. PMID: 17430345
-
Effect of Lactobacillus rhamnosus GG immunopathologic changes in chronic mouse asthma model.J Microbiol Immunol Infect. 2019 Dec;52(6):911-919. doi: 10.1016/j.jmii.2019.03.002. Epub 2019 Mar 23. J Microbiol Immunol Infect. 2019. PMID: 30952512
-
Benefit:Risk Profile of Budesonide in Obstructive Airways Disease.Drugs. 2019 Nov;79(16):1757-1775. doi: 10.1007/s40265-019-01198-7. Drugs. 2019. PMID: 31549299 Free PMC article. Review.
Cited by
-
The potential immunomodulatory role of the gut microbiota in the pathogenesis of asthma: an in vitro study.Sci Rep. 2023 Nov 13;13(1):19721. doi: 10.1038/s41598-023-47003-0. Sci Rep. 2023. PMID: 37957277 Free PMC article.
-
Progress of linking gut microbiota and musculoskeletal health: casualty, mechanisms, and translational values.Gut Microbes. 2023 Dec;15(2):2263207. doi: 10.1080/19490976.2023.2263207. Epub 2023 Oct 6. Gut Microbes. 2023. PMID: 37800576 Free PMC article. Review.
-
The lung-gut crosstalk in respiratory and inflammatory bowel disease.Front Cell Infect Microbiol. 2023 Aug 23;13:1218565. doi: 10.3389/fcimb.2023.1218565. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37680747 Free PMC article. Review.
-
Distinguishing science from pseudoscience in commercial respiratory interventions: an evidence-based guide for health and exercise professionals.Eur J Appl Physiol. 2023 Aug;123(8):1599-1625. doi: 10.1007/s00421-023-05166-8. Epub 2023 Mar 14. Eur J Appl Physiol. 2023. PMID: 36917254 Free PMC article. Review.
-
Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study.Respir Res. 2022 Nov 19;23(1):321. doi: 10.1186/s12931-022-02246-9. Respir Res. 2022. PMID: 36403054 Free PMC article.
References
-
- Navarro S, Cossalter G, Chiavaroli C, Kanda A, Fleury S, Lazzari A, Cazareth J, Sparwasser T, Dombrowicz D, Glaichenhaus N, Julia V. The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways. Mucosal Immunol. 2011;4(1):53–65. doi: 10.1038/mi.2010.51. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials